Victory Capital Management’s Akero Therapeutics AKRO Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $2.77M | Buy |
51,830
+16,714
| +48% | +$892K | ﹤0.01% | 1500 |
|
2025
Q1 | $1.42M | Buy |
35,116
+27,881
| +385% | +$1.13M | ﹤0.01% | 1642 |
|
2024
Q4 | $201K | Sell |
7,235
-135
| -2% | -$3.76K | ﹤0.01% | 2235 |
|
2024
Q3 | $211K | Buy |
+7,370
| New | +$211K | ﹤0.01% | 2214 |
|
2024
Q1 | – | Sell |
-13,880
| Closed | -$324K | – | 2476 |
|
2023
Q4 | $324K | Sell |
13,880
-179,572
| -93% | -$4.19M | ﹤0.01% | 2104 |
|
2023
Q3 | $9.78M | Sell |
193,452
-104,120
| -35% | -$5.27M | 0.01% | 1027 |
|
2023
Q2 | $13.9M | Buy |
297,572
+93,990
| +46% | +$4.39M | 0.02% | 913 |
|
2023
Q1 | $7.79M | Buy |
203,582
+199,495
| +4,881% | +$7.63M | 0.01% | 1101 |
|
2022
Q4 | $224K | Sell |
4,087
-15,127
| -79% | -$829K | ﹤0.01% | 2243 |
|
2022
Q3 | $654K | Sell |
19,214
-702
| -4% | -$23.9K | ﹤0.01% | 1929 |
|
2022
Q2 | $188K | Sell |
19,916
-10
| -0.1% | -$94 | ﹤0.01% | 2365 |
|
2022
Q1 | $209K | Buy |
19,926
+717
| +4% | +$7.52K | ﹤0.01% | 2398 |
|
2021
Q4 | $406K | Sell |
19,209
-2,763
| -13% | -$58.4K | ﹤0.01% | 2259 |
|
2021
Q3 | $491K | Buy |
21,972
+31
| +0.1% | +$693 | ﹤0.01% | 2184 |
|
2021
Q2 | $544K | Sell |
21,941
-1,021
| -4% | -$25.3K | ﹤0.01% | 2164 |
|
2021
Q1 | $666K | Sell |
22,962
-1,058
| -4% | -$30.7K | ﹤0.01% | 2072 |
|
2020
Q4 | $620K | Sell |
24,020
-1,022
| -4% | -$26.4K | ﹤0.01% | 1973 |
|
2020
Q3 | $771K | Sell |
25,042
-8,666
| -26% | -$267K | ﹤0.01% | 1816 |
|
2020
Q2 | $840K | Sell |
33,708
-34,180
| -50% | -$852K | ﹤0.01% | 1806 |
|
2020
Q1 | $1.44M | Buy |
67,888
+66,280
| +4,122% | +$1.41M | ﹤0.01% | 1726 |
|
2019
Q4 | $36K | Sell |
1,608
-1,021
| -39% | -$22.9K | ﹤0.01% | 2613 |
|
2019
Q3 | $60K | Buy |
2,629
+1,021
| +63% | +$23.3K | ﹤0.01% | 2598 |
|
2019
Q2 | $31K | Buy |
+1,608
| New | +$31K | ﹤0.01% | 1775 |
|